Raluca Ioana Marin
6 Papers
Raluca Ioana Marin is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world
Sahith Kudaravalli,Daniel Q. Huang,Ming-Lun Yeh,Lindsey Trinh,P.C. Tsai,Yao-Chun Hsu,Leslie Y. Kam,V. H. Nguyen,Eiichi Ogawa,Dong Hyun Lee,Takanori Ito,Tsunamasa Watanabe,Masaru Enomoto,Carmen Monica Preda,Michael K.L. Ko,Rex Wan-Hin Hui,Masanori Atsukawa,Takanori Suzuki,S. Marciano,Ana Barreira,Son Do,Haruki Uojima,Hirokazu Takahashi,Sabrina Xz Quek,Htet Htet Toe Wai Khine,Masatoshi Ishigami,Norio Itokawa,Min Seok Go,Ritsuzo Kozuka,Raluca Ioana Marin,Irina Sandra,Jiayi Li,Jian Q. Zhang,Christopher Wong,Yoko Yoshimaru,Dang Hai Vo,C.-H. Tseng,Chul-jin Lee,Kaori Inoue,Mayumi Maeda,Joseph Hoang,Angela Chau,Wan-Long Chuang,Chia-Yen Dai,Jee-Fu Huang,Chung-Feng Huang,Maria Buti,Yasuhito Tanaka,Adrián Gadano,M. Yuen,Ramsey Cheung,Seng Gee Lim,Huy N. Trinh,Hidenori Toyoda,Ming-Lung Yu,Mindie H. Nguyen +55 more
TL;DR: This study examines sex and ethnic disparities in hepatitis B evaluation and treatment globally, utilizing real-world data from the REAL-B consortium, highlighting the underutilization of lifesaving oral antiviral therapy.
11
Hepatocellular Carcinoma in Patients with Chronic Hepatitis C and Liver Cirrhosis Treated with DAA: A Focused Review
Săndica Bucurică,A. Nancoff,Raluca Ioana Marin,Carmen Monica Preda +3 more
1
Non-alcoholic fatty liver disease in diabetes mellitus patients on chronic hemodialysis – A case series addressing cardiovascular and mortality risks
Roxana Adriana Stoica,Laura Tribus,Raluca Ioana Marin,Tara David,Carmen Monica Preda,Ioana Bica,Cristian Serafinceanu +6 more
TL;DR: In this article , a case series describes NAFLD associated factors and survival in type 2 diabetes patients (T2DM) who have ESRD treated with hemodialysis.
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study.
Aivien Do,Hidenori Toyoda,Jie Li,Satoshi Yasuda,Pei-Chien Tsai,Ming-Lun Yeh,Huy N. Trinh,Angela Chau,Daniel Q. Huang,Eiichi Ogawa,Takanori Ito,Ritsuzo Kozuka,Masanori Atsukawa,S. Marciano,Takashi Honda,Tsunamasa Watanabe,Norio Itokawa,Carmen Monica Preda,C.-H. Tseng,Ana Barreira,Kaori Inoue,Hirokazu Takahashi,Haruki Uojima,Keigo Kawashima,Yao-Chun Hsu,Raluca Ioana Marin,Irina Sandra,Masatoshi Ishigami,Jiayi Li,Jian Zhang,Son Do,Mayumi Maeda,Donghyun Lee,Wan-Long Chuang,Chia-Yen Dai,Jee-Fu Huang,Chung-Feng Huang,Ramsey Cheung,Maria Buti,Yasuhito Tanaka,M. Yuen,Masaru Enomoto,Adrián Gadano,Seng Gee Lim,Ming-Lung Yu,Chao Wu +45 more
TL;DR: This study investigates the distribution, characteristics, and natural history of diverse types of indeterminate chronic hepatitis B, identifying novel types and phase transition probabilities in a heterogeneous patient group.
Antiviral therapy substantially reduces hepatocellular carcinoma risk in chronic Hepatitis B patients in the indeterminate phase.
Daniel Q. Huang,Andrew Tran,Ming-Lun Yeh,Satoshi Yasuda,Pei-Chien Tsai,Chung-Feng Huang,Chia-Yen Dai,Eiichi Ogawa,Masatoshi Ishigami,Takanori Ito,Ritsuzo Kozuka,Masaru Enomoto,Takanori Suzuki,Yoko Yoshimaru,Carmen Monica Preda,Raluca Ioana Marin,Irina Sandra,Sally Tran,Sabrina Xz Quek,Htet Khine,Norio Itokawa,Masanori Atsukawa,Haruki Uojima,Tsunamasa Watanabe,Hirokazu Takahashi,K. Inoue,Mayumi Maeda,Joseph Hoang,Lindsey Trinh,Scott Barnett,Ramsey Cheung,Seng Gee Lim,Huy N. Trinh,Wan-Long Chuang,Yasuhito Tanaka,Hidenori Toyoda,Ming-Lung Yu,M. Hong Nguyen +37 more
TL;DR: In this paper , the authors evaluated the association between antiviral therapy and HCC risk in the indeterminate phase in chronic hepatitis B (CHB) patients and found that antiviral treatment was an independent predictor of reduced HC risk.